Evli High Yield vs UBS Lux Equity Fund Biotech USD

Evli High Yield vs UBS Lux Equity Fund Biotech USD

1. Evli High Yield

  • Security

    Evli High Yield B

  • Fee

    1.11%

  • ISIN

    FI0008803929

  • Holdings

    18

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 18 holdings in Evli High Yield, where the largest holding is Iliad Holding (1.39), followed by Lorca Telecom Bondco (1.38) and BPCE (1.27). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Evli High Yield and UBS Lux Equity Fund Biotech USD.

Evli High Yield UBS Lux Equity Fund Biotech USD
1. Iliad Holding SAS
France
1.39 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Lorca Telecom Bondco SAU
Spain
1.38 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. BPCE SA
France
1.27 %
3. Moderna Inc
9.21 %
4. Allianz SE
Germany
1.16 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Zegona Finance Plc
UK
1.08 %
5. AbbVie Inc
USA
5.53 %
6. Telefónica Europe BV
Netherlands
1.07 %
6. Gilead Sciences Inc
USA
4.66 %
7. Dynamo Newco II GmbH
Germany
1.05 %
7. Amgen Inc
4.3 %
8. Nidda Healthcare Holding GmbH
Germany
1.05 %
8. BioNTech SE
4.13 %
9. Ardonagh Finco Ltd
UK
1.04 %
9. Karuna Therapeutics Inc
3.75 %
10. Ziggo Bond Company BV
Netherlands
1.03 %
10. Royalty Pharma Plc
3.37 %
11. UPCB Finance VII Ltd
Cayman Islands
1.02 %
-
12. Fabbrica Italiana Sintetici SpA
Italy
1 %
-
13. Progroup AG
Switzerland
0.99 %
-
14. NTI Group Holding ApS
Denmark
0.98 %
-
15. Boels Topholding NV
Netherlands
0.98 %
-
16. Eroski Sociedad Cooperativa
Spain
0.97 %
-
17. Intrum AB
0.92 %
-
18. IQVIA Inc
0.92 %
-

The list of fund holdings was last updated on June 5, 2025.